ArticleTherapeutics and clinical risk management2020

Development and Validation of a Novel Nomogram for Predicting Tumor-Distant-Metastasis in Patients with Early T1-2 Stage Lung Adenocarcinoma.

WeiGuo Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.